Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Plant Physiol ; 284: 153981, 2023 May.
Article in English | MEDLINE | ID: mdl-37054580

ABSTRACT

The importance of oats has increased because of their high nutritional value and health benefits in the human diet. High-temperature stress during the reproductive growth period has a detrimental effect on grain morphology by changing the structure and concentration of several seed-storage proteins. DA1, a conserved ubiquitin-proteasome pathway component, plays an important role in regulating grain size by controlling cell proliferation in maternal integuments during the grain-filling stage. However, there have been no reports or studies on oat DA1 genes. In this study, we identified three DA1-like genes (AsDA1-2D, AsDA1-5A, and AsDA1-1D) using genome-wide analysis. Among these, AsDA1-2D was found to be responsible for high-temperature stress tolerance via a yeast thermotolerance assay. The physical interaction of AsDA1-2D with oat-storage-globulin (AsGL-4D) and a protease inhibitor (AsPI-4D) was observed using yeast two-hybrid screening. A subcellular localization assay revealed that AsDA1-2D and its interacting proteins are localized in the cytosol and plasma membrane. An in vitro pull-down assay showed that AsDA1-2D forms a complex with both AsPI-4D and AsGL-4D. An in vitro cell-free degradation assay showed that AsGL-4D was degraded by AsDA1-2D under high-temperature conditions and that AsPI-4D inhibited the function of AsDA1-2D. These results suggest that AsDA1-2D acts as a cysteine protease and negatively regulates oat-grain-storage-globulin under heat stress.


Subject(s)
Globulins , Thermotolerance , Humans , Avena/metabolism , Saccharomyces cerevisiae/metabolism , Seeds/metabolism , Edible Grain/metabolism , Heat-Shock Response , Globulins/genetics , Globulins/metabolism
2.
Osong Public Health Res Perspect ; 2(2): 89-93, 2011 Sep.
Article in English | MEDLINE | ID: mdl-24159457

ABSTRACT

OBJECTIVE: Prediction of influenza incidence among outpatients from an influenza surveillance system is important for public influenza strategy. METHODS: We developed two influenza prediction models through influenza surveillance data of the Korea Centers for Disease Control and Prevention (each year, each province and metropolitan city; total reported patients with influenza-like illness stratified by age) for 6 years from 2005 to 2010 and disease-specific data (influenza code J09-J11, monthly number of influenza patients, total number of outpatients and hospital visits) from the Health Insurance Review and Assessment service. RESULTS: Incidence of influenza in each area, year, and month was estimated from our prediction models, which were validated by simulation processes. For example, in November 2009, Seoul and Joenbuk, the final number of influenza patients calculated by prediction models A and B underestimated actual reported cases by 64 and 833 patients, respectively, in Seoul and 6 and 9 patients, respectively, in Joenbuk. R-square demonstrated that prediction model A was more suitable than model B for estimating the number of influenza patients. CONCLUSION: Our prediction models from the influenza surveillance system could estimate the nationwide incidence of influenza. This prediction will provide important basic data for national quarantine activities and distributing medical resources in future pandemics.

3.
J Korean Med Sci ; 25(7): 1109-12, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20592911

ABSTRACT

This report describes the pattern of the spread of the pandemic H1N1 2009 and compares 3 monitoring tools until the 57th week or January 31, 2010. The 1st week was from December 28th, 2008 to January 3rd, 2009. A total of 740,835 patients were reported to be infected with pandemic H1N1 2009 and 225 patients were reported to have died of pandemic H1N1 2009. The number of patients aged from 7 to 12 was the largest (183,363 patients in total) but the virus spread and then was suppressed most quickly among the children between 13 and 18. The region-determinant incidence of patients showed diverse patterns according to regions. The peak of the ILI per thousand was at the 45th week, the number of antiviral prescriptions reached its peak at the 44th week, and the peak based on reported patients was the 46th week. As of February 3 2010, the outbreak passed through the peak and has gradually subsided. Now it is time for the government and the academic world to review this outbreak, efficacy of vaccination, and further preparation and response for the next pandemic.


Subject(s)
Disease Outbreaks , Influenza A Virus, H1N1 Subtype/pathogenicity , Influenza, Human/epidemiology , Adolescent , Adult , Age Distribution , Antiviral Agents/therapeutic use , Child , Child, Preschool , Humans , Infant , Infant, Newborn , Influenza Vaccines/therapeutic use , Influenza, Human/drug therapy , Influenza, Human/mortality , Korea/epidemiology , Middle Aged , Sentinel Surveillance , Young Adult
4.
J Korean Med Sci ; 20(6): 941-6, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16361801

ABSTRACT

Eleven cases of human brucellosis occurred among livestock workers and a veterinarian who lived and worked in a rural area around Jeongeup City, Jeollabuk-Do, Korea from February 2003 to August 2003. Eight of the patients had taken care of Korean native cattle that were infected with bovine brucellosis and had already been slaughtered. Two of the patients had taken care of dairy cattle, and one case was a veterinarian who acquired the disease through an accidental contact with infected cattle while assisting in calf delivery. Eleven cases were identified by serologic work ups and four cases were identified via positive blood cultures. This study shows that the Republic of Korea is no longer free of human brucellosis, Brucella abortus biotype 1. We reviewed the patients' characteristics and serologic data during the one-year follow up period, and we also discuss on the efficacy and side effects of the rifampin and doxycyline regimen used for the treatment of human brucellosis.


Subject(s)
Brucellosis/epidemiology , Adult , Animal Husbandry , Animals , Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/therapeutic use , Antibodies, Bacterial/blood , Base Sequence , Brucella abortus/genetics , Brucella abortus/immunology , Brucella abortus/isolation & purification , Brucellosis/drug therapy , Brucellosis/microbiology , Brucellosis/transmission , Brucellosis, Bovine/transmission , Cattle , DNA, Bacterial/genetics , Disease Outbreaks , Doxycycline/adverse effects , Doxycycline/therapeutic use , Female , Humans , Korea/epidemiology , Male , Middle Aged , Occupational Diseases/drug therapy , Occupational Diseases/epidemiology , Occupational Diseases/immunology , Occupational Diseases/microbiology , Rifampin/adverse effects , Rifampin/therapeutic use , Veterinarians
SELECTION OF CITATIONS
SEARCH DETAIL
...